Catalyst Wire Dossier Catalyst Wire Dossier

Basis

nicotinamide riboside with pterostilbene · Elysium Health
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Basis, covering 2016-08-01 to 2024-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Protection From Acute Kidney Injury (AKI) With Basis™ Treatment [Phase 2]

See pricing